Clinical Trials Browser

Phase 2 × Breast Neoplasms × Medroxyprogesterone Acetate × Clear all

NCT00577122 2023-10-16

Medroxyprogesterone +/- Cyclophosphamide & Methotrexate in Hormone Receptor-Negative Recurrent/Metastatic Breast Cancer

Phase 2 Completed

30 enrolled 13 charts

Breast Neoplasms